Sparks Joshua R, Porter Ryan R, Youngstedt Shawn D, Bowyer Kimberly P, Durstine J Larry, Wang Xuewen
Department of Exercise Science, University of South Carolina, Columbia, SC.
Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ.
Sleep Adv. 2021 Jan 28;1(1):zpab001. doi: 10.1093/sleepadvances/zpab001. eCollection 2020.
This study examined how glucose, glucose regulatory hormones, insulin sensitivity, and lipoprotein subclass particle concentrations and sizes change with sleep restriction during weight loss elicited by calorie restriction.
Overweight or obese adults were randomized into an 8-week calorie restriction intervention alone (CR, = 12; 75% female; body mass index = 31.4 ± 2.9 kg/m) or combined with sleep restriction (CR+SR, = 16; 75% female; body mass index = 34.5 ± 3.1 kg/m). Participants in both groups were given the same instructions to reduce calorie intake. Those in the CR+SR group were instructed to reduce their habitual time-in-bed by 30-90 minutes 5 days each week with 2 ad libitum sleep days. Fasting venous blood samples were collected at pre- and post-intervention.
Differential changes were found between the two groups ( = 0.028 for group × time interaction) in glucagon concentration, which decreased in the CR group ( = 0.016) but did not change in CR+SR group. Although changes in mean HDL particle (HDL-P) size and visfatin concentration were not statistically different between groups ( = 0.066 and 0.066 for group×time interaction, respectively), mean HDL-P size decreased only in the CR+SR group (Cohen's = 0.50, = 0.022); visfatin concentrations did not change significantly in either group but appeared to decrease in the CR group (Cohen's = 0.67, = 0.170) but not in the CR+SR group (Cohen's = 0.43, = 0.225).
These results suggest that moderate sleep restriction, despite the presence of periodic ad libitum sleep, influences lipoprotein subclass particles and glucose regulation in individuals undergoing calorie restriction.Clinical trial registration: ClinicalTrials.gov (NCT02413866, Weight Outlooks by Restriction of Diet and Sleep).
本研究探讨了在热量限制引起体重减轻期间,葡萄糖、葡萄糖调节激素、胰岛素敏感性以及脂蛋白亚类颗粒浓度和大小如何随睡眠限制而变化。
超重或肥胖的成年人被随机分为两组,一组仅进行为期8周的热量限制干预(CR组,n = 12;75%为女性;体重指数 = 31.4 ± 2.9 kg/m²),另一组是热量限制与睡眠限制相结合(CR + SR组,n = 16;75%为女性;体重指数 = 34.5 ± 3.1 kg/m²)。两组参与者都收到了相同的减少热量摄入的指导。CR + SR组的参与者被要求每周5天将习惯的卧床时间减少30 - 90分钟,另外2天自由睡眠。在干预前后采集空腹静脉血样本。
两组之间在胰高血糖素浓度上发现了差异变化(组×时间交互作用的P = 0.028),CR组胰高血糖素浓度下降(P = 0.016),而CR + SR组没有变化。尽管两组之间平均高密度脂蛋白颗粒(HDL - P)大小和内脂素浓度的变化没有统计学差异(组×时间交互作用的P分别为0.066和0.066),但仅CR + SR组的平均HDL - P大小下降(科恩d值 = 0.50,P = 0.022);两组内脂素浓度均无显著变化,但CR组似乎下降(科恩d值 = 0.67,P = 0.170),而CR + SR组没有下降(科恩d值 = 0.43,P = 0.225)。
这些结果表明,尽管存在周期性的自由睡眠,适度的睡眠限制仍会影响热量限制个体的脂蛋白亚类颗粒和葡萄糖调节。临床试验注册:ClinicalTrials.gov(NCT02413866,饮食和睡眠限制对体重的影响)。